If you don't remember your password, you can reset it by entering your email address and clicking the Reset Password button. You will then receive an email that contains a secure link for resetting your password
If the address matches a valid account an email will be sent to __email__ with instructions for resetting your password
1 Drs. Becerril-Ángeles and Vargas contributed equally to this work.
Martín Becerril-Ángeles
Footnotes
1 Drs. Becerril-Ángeles and Vargas contributed equally to this work.
Affiliations
Departamento de Alergia e Inmunología Clínica, Hospital de Especialidades, Centro Médico Nacional La Raza, Instituto Mexicano del Seguro Social, Mexico City, MexicoHospital Médica Sur, Mexico City, Mexico
1 Drs. Becerril-Ángeles and Vargas contributed equally to this work.
Affiliations
Departamento de Investigación en Hiperreactividad Bronquial, Instituto Nacional de Enfermedades Respiratorias Ismael Cosío Villegas, Mexico City, Mexico
Major atopic diseases such as atopic dermatitis (AD), allergic rhinitis (AR), and asthma share the same atopic background, but they often show differences in their epidemiological behavior.
Objective
We aimed to report the profile of these atopic diseases in a large Mexican population, including their age-related incidences, male:female (M:F) ratios, recent time trends, and association with altitude.
Methods
Registries from the largest, nationwide health institution in Mexico (more than 34 million insured subjects), were reviewed. New cases of AD, AR, and asthma diagnosed each year by family physicians from 2007 to 2019 were adjusted by the corresponding insured population to estimate incidence rates.
Results
Incidences of the 3 atopic diseases were highest in the 0–4 years age-group and progressively decreased thereafter until adolescence. Asthma and AR, but not AD, were more frequent in males during childhood (M:F ratios of 1.5, 1.3, and 0.95, respectively), but predominated in females during adulthood (M:F ratios of 0.52, 0.68, and 0.73, respectively). Time trends showed an initial increasing trend of annual incidences, with a peak around 2009–2011, and a downward trend afterward. This decreasing trend was seen in all age-groups and was more evident for AD (∼50% drop) and asthma (∼40% drop) than for AR (∼20% drop). Geographical distribution suggested that incidences of asthma and AR, but not of AD, had an inverse association with altitude.
Conclusion
Annual incidences of the 3 major atopic diseases have declined in recent years in almost all age groups, and their epidemiological profile during the life span showed contrasting differences according to age, sex, and ecological association with altitude, mainly regarding AD.
An epidemic rising trend in the prevalence of atopic diseases was a worldwide phenomenon between 1960s and the late 1990s, but this trend was followed by a plateau in many countries, lacking until now a clear explanation for this behavior.
Atopic diseases comprise 4 major conditions: atopic dermatitis (AD), food allergy, allergic rhinitis (AR), and asthma. A number of factors have been associated with the development of these diseases, including genetic traits,
By contrast, some conditions seem to be protective for the development of atopic diseases as, for example, exposure to bacterial endotoxins from livestock, mainly during early life.
Moreover, the capability of skin, intestinal and/or respiratory microbiota to modulate immune responses and the possible role of its dysbiosis in allergy is gaining interest.
These allergic diseases are involved in the so-called atopic march. The term "atopic march" was coined to depict the progressive appearance of several allergic diseases during childhood, usually following the sequence of AD, food allergy, AR, and asthma.
The extended “epithelial barrier hypothesis” postulates that even trace amounts of substances linked to industrialization, urbanization, and modern life can damage epithelial barriers and increase bacterial translocation.
which in turn promotes the development of food and airway allergies through an early systemic sensitization, as has been shown by genetic association studies, cross-sectional studies, cohort studies, and experimental animal models.
The severity of AD in infancy seems to be an important risk factor for respiratory allergy later in life. Thus, infants with early-onset persistent AD had a three-fold risk for asthma and AR in the next few years, as compared with children who developed AD after 2 years of age.
In a Swedish cohort, in children under 3 years of age the inception of asthma by age 7 was different in infants with severe AD and those with mild AD, amounting to >60% and 20%, respectively.
In order to gain insights about the time trends from 2007 to 2019 in annual incidences of AD, AR, and asthma, and how these incidences change according to sex and age-group, databases of the Instituto Mexicano del Seguro Social (IMSS), which is the largest health institution in Mexico, were reviewed. In 2019, its workforce of more than 17 800 family physicians across the country provided medical services to the population of insured subjects formally registered in a first-contact medical unit (non-government employees and their spouses, daughters, sons, and parents). This insured population ranged from ∼34.8 (year 2007) to ∼50.9 (year 2019) million subjects, representing more than one-third of the Mexican population. On the other hand, Mexico has a large diversity of regional conditions, including altitude, and it has been previously described that there is an inverse association between asthma and altitude, starting from 1500 m above sea level.
Becerril-Angeles M., Vargas M.H., Medina-Reyes I.S., Rascon-Pacheco R.A. Factors related to changes in the asthma male:female ratio by age in 403 Mexican counties. Ann Allergy Asthma Immunol. 2019;123(3):288-292 e1.
Briefly, medical consultations provided and registered by each family physician are concentrated in a nationwide database called SUI27. From this database, medical diagnoses from patients of any age made each year from 2007 to 2019 concerning first-time medical consultations (ie, newly diagnosed cases) were analyzed both in a nationwide context and broken down among the ∼740 counties where the IMSS provides medical services to its ordinary regimen insured population. Although these counties correspond to ∼27% of all Mexican counties, they concentrate ∼79% of the Mexican population. Medical units in these counties also provide medical care to insured persons from the nearest small, low-populated rural counties not having medical units. Atopic diseases included in the study were asthma (ICD-10 codes J45 and J46), AR (ICD-10 code J30), and AD (ICD-10 code L20). According to institutional regulations, for establishing the diagnosis of asthma, AR and/or AD, family physicians must adhere to official and updated clinical practice guidelines,
Instituto Mexicano del Seguro Social. Guía de práctica clínica. Diagnóstico y tratamiento del asma en mayores de 18 años. Evidencias y recomendaciones: Instituto Mexicano del Seguro Social; 2009. Available from: https://www.imss.gob.mx/sites/all/statics/guiasclinicas/000GER_Asma.pdf.
Instituto Mexicano del Seguro Social. Guía de práctica clínica. Diagnóstico y tratamiento de rinitis alérgica. Evidencias y recomendaciones. Ciudad de México: Instituto Mexicano del Seguro Social; 2017. Available from: https://www.imss.gob.mx/sites/all/statics/guiasclinicas/041GER.pdf.
Instituto Mexicano del Seguro Social. Guía de práctica clínica. Tratamiento de la dermatitis atópica. Evidencias y recomendaciones. Ciudad de Méxio: Instituto Mexicano del Seguro Social; 2014. Available from: https://www.imss.gob.mx/sites/all/statics/guiasclinicas/706GER.pdf.
which in turn follow international recommendations, thus assuring a reasonable level of homogeneous diagnostic criteria. Moreover, family physicians are specialists with a full three-year residency for training in the diagnosis and treatment of the most frequent diseases occurring in the insured population. Food allergy, anaphylaxis, urticaria, and allergy to drugs were not included in the analysis because these are more complex diseases that often require the diagnostic workup at the secondary or tertiary care level. The counties’ altitudes above sea level were obtained from the publicly available database of the National Institute of Statistics and Geography (INEGI).
Because this was a retrospective analysis of a de-identified institutional database, it was deemed unnecessary obtaining the approval from an ethics and scientific review board.
Data analysis
Because only newly diagnosed cases were analyzed, when they were divided by the cumulative number of insured subjects of the same sex and in the same location, time-period and age-group, incidence rate was obtained, ie, the number of insured subjects (denominator) exactly matched the characteristics of cases (numerator) regarding sex, age, years analyzed, and geographical limits. Crude and age-adjusted (Poisson regression) male:female (M:F) ratios were calculated using incidence in subjects <15 years old and subjects ≥15 years old. Non-paired Student's t-test was used for group comparisons. Statistical significance was set at two-tailed p < 0.05. Data were processed in Microsoft Excel spreadsheets.
Results
As can be seen in Table 1, the population studied ranged from ∼34.8 to ∼50.9 million insured subjects, and in the 13 years studied the number of patients diagnosed with any of the 3 atopic diseases (AD, asthma, or AR) totalized 9.7 million (∼744,000 patients per year).
Table 1Nationwide annual incidences of the 3 major atopic diseases by year
In males, children 0–4 years old had the highest incidence rates of the 3 atopic diseases (AD, asthma, and AR), followed by a sharp decline until adolescence for AD, a less notable drop for asthma, and even a lower decrease for AR (Fig. 1). At 20–24 years old, incidences of AD, asthma and AR represented 19.5%, 13.8% and 35.4% of the incidence at 0–4 years old, respectively. In general terms, after adolescence, incidence of all diseases continued declining until they reached a relative plateau in young adulthood, with a final drop at age 80 years and more.
Fig. 1Nationwide incidence rates of atopic dermatitis, asthma and allergic rhinitis by sex and age group. Symbols represent the 13 years (2007–2019) averages and standard deviation of annual incidence calculated from registries of new cases occurring in an insured population ranging from ∼34.8 million (2007) to ∼50.9 million subjects (2019).
In contrast, in females, after an initial decline of atopic diseases until adolescence there was a small increase in the AD and AR incidences in the 15-19 years-old group, and a second, more gradual increment of all incidences, peaking at 40–54 years old, mainly in asthma and AR.
These trends in the male and female incidences determined that during childhood males were more frequently affected than females, both for asthma and AR (M:F ratios 1.500, and 1.296, respectively), while AD did not show differences between both sexes (M:F ratio 0.953) (Table 2). After adolescence, the M:F ratio switched to a higher incidence in females than in males in all 3 atopic diseases (M:F ratios 0.519, 0.677, and 0.735, respectively).
Table 2Annual average incidence (per 100,000 insured subjects) of allergic diseases and the male:female (M:F) ratios
Data correspond to mean ± standard error of 13 years (2007–2019) or to adjusted M:F ratio (95% confidence intervals), from a population size ranging from ∼34.8 (year 2007) to ∼50.9 (year 2019) million subjects.
Fig. 2 shows altitude above sea level of the 10n counties with the highest incidences (evaluated as the average annual incidences 2007–2019) of asthma, AR, and AD, as well as the 10 counties with the lowest incidences of these diseases. As can be observed in this figure, there was a clear inverse relationship between altitude and incidences of asthma and AR, but not between altitude and AD incidence (see also Supplementary Table S1).
Fig. 2Altitude above sea level of counties with the highest and lowest incidences (evaluated as the average annual incidences 2007–2019) of atopic dermatitis, asthma, and allergic rhinitis. These counties were selected from 365 Mexican counties with >10,000 insured people. Data correspond to the mean ± standard error of the mean. †p < 0.001, n. s. = non statistically significant (nonpaired Student's t-test).
The time trend analysis of the 13 years studied (2007–2019) showed that the 3 atopic diseases had a descending trend from 2011 onward (Fig. 3 and Table 1). In agreement with this global tendency, when broken down by age group it was evident that annual incidences in almost all age groups peaked around 2009–2011, followed by a downward trend (Supplementary Fig. S1-S3). This latter decreasing trend was quite evident for AD (Supplementary Fig. S1) and asthma (Supplementary Fig. S2), which in 2019 reached a final drop of ∼50% and ∼40% of their maximal incidences, respectively, while for AR (Supplementary Fig. S3) it was much less notorious (∼20% drop), and even in some age-groups (eg, 5-9- and 10-14-years old groups) the increasing trend was maintained throughout the studied period. In all cases, these time trends showed a similar behavior for male and female patients.
Fig. 3Time trends in nationwide annual incidence rates of atopic dermatitis, asthma, and allergic rhinitis. Data correspond to the cumulative number of all new cases diagnosed each year by family physicians among 34.8 million (year 2007) to 50.9 million (year 2019) insured subjects.
In the present study, we describe the lifetime incidence patterns of the 3 major diseases involved in the atopic march in a very large population. Our results showed that these diseases had their greatest annual incidences within the first 4 years of age, with a subsequent decline thereafter, mainly in males.
Many studies have analyzed the frequency of AD, AR, and asthma according to age, yielding contrasting results. Czarnowicki et al.
illustrated the atopic march with an initial peak of AD rate in the 1–3 years age group, followed by a peak of asthma at 4–6 years of age, and by a plateau of AR from 10 years of age onward. In turn, Hill and Spergel.
opined that AD and asthma are diagnosed more frequently at 0–5 years of age, and at 12–17 years of age, respectively, while AR reaches a plateau from 24 years of age onward. Gough et al.
showed that AD was 5 times more frequent at an age of 12 years than at 26 years. In a meta-analysis of 7 population-based cohorts addressing AD prevalence until age 26 years,
the study showing a prevalence trend that resembles our findings, ie, with the highest peak in early life and a sharp decline thereafter. Although AR is generally thought to be developed in late childhood, Eriksson et al.
found that its highest prevalence occurred in subjects between 30 and 40 years of age, with a gradual decline thereafter. Our results followed at some extent this pattern, but only in females, while males had a decreasing trend of AR incidence throughout life.
The use of incidence in our study might partially explain the contrasting results with respect to those studies using prevalence, but a complex array of other factors could be also involved, such as ethnicity, environmental pollution, dietary habits, sedentary lifestyle, antibiotics use, exposure to chemicals, marginalization, and geographical conditions, among others.
With respect to incidences by sex, at least for AR and asthma our results resemble the well-known pattern in which incidence is higher among boys during childhood, but changes in adolescence, and then females become more affected than males and continue so during the rest of the life.
We found that AD, by contrast, did not present the increased frequency in males during childhood (Table 2). This contrasting behavior of AD with respect to asthma and AR has also been documented by some cohort studies. For example, Gough et al.
showed an increased prevalence of AD in females during childhood and up to 20 years of age, while asthma and AR displayed the well-known male predominance during this time period. Likewise, Burr et al.
showed that, like our results, there was a similar prevalence of AD in both sexes up to 10 years of age, with a clear female predominance from 10 to 18 years. Mohrenschlager et al.
found a slight female predominance in the prevalence of AD among children aged 5–7 years, which was explained by a higher skin surface pH and lower stratum corneum hydration in girls, as compared with boys. Although the higher female frequency of atopic disease in adulthood is usually considered to be related to changes in sexual hormones, this claim is mostly based on in vitro and animal model studies, and it has not been proved conclusively in the clinical setting. In this context, a recent ecological study found that the M:F ratio in asthma incidence during adulthood did not parallel hormonal changes, and that factors such as population density and acute respiratory tract infections, among others, might also be involved.
The lack of a major role of hormonal influence is clearly observed in Fig. 1, where inception of the atopic disease continues to be higher in women, even if they are in post-menopausal age-groups.
A worrisome epidemic increase in the prevalence of asthma, AR and AD was observed worldwide throughout the second half of the 1900s century.
In our analysis of 13 years it was evident that after reaching a peak around 2009–2011, the annual incidence of asthma and AD began to decrease in all age groups, while yearly incidence of AR seemed to maintain a flat trend or even to increase in some age groups. In the last few years, a number of reports from several countries have evaluated the time trends of major atopic diseases by analyzing at least 3 different time-points.
As can be seen in the Supplementary Fig. 4, in general terms their results are in agreement with ours in the sense that the frequency of these diseases appear to be decreasing in recent years. The cause of the decreasing trend of the major atopic diseases, particularly asthma, is largely unknown. One of the most widely accepted explanation of the epidemic rise of allergic diseases is the hygiene hypothesis, which postulates that the lower exposure to microorganisms or their products conveys an immunological bias toward allergy.
It has been proposed that Streptococcus pyogenes, the causal agent of scarlet fever, might be involved in the hygiene hypothesis due to the strong temporal, seasonal and geographical inverse association of scarlet fever and asthma.
Such an increase in the incidence of scarlet fever probably implies that the rate of asymptomatic nasopharyngeal carriage of Streptococcus pyogenes in the general population was also increased. Thus, although we have no evidence that the incidence of scarlet fever has increased in Mexico, it may be possible that a higher frequency of Streptococcus pyogenes carriage explains the decreasing trend of asthma (and AD) from 2011 onward. An alternative explanation is based in the strong inverse relationship between neural tube defects and asthma, already demonstrated in Mexico and the United States.
Dirección General de Epidemiología, Secretaría de Salud, México. Anuario de Morbilidad 1984 -2020. https://epidemiologia.salud.gob.mx/anuario/html/index.html. Accessed March 23, 2022.
we could corroborate that both diseases still maintained a strong inverse temporal association during the same time-period used in the present study (Supplementary Fig. S5). A possible explanation of this association is that folic acid, which is a well-known preventer of neural tube defects, might be simultaneously promoting the development of asthma and/or other atopic diseases via epigenetic mechanisms such as histone methylation.
Interestingly, AD exhibited some differences with respect to asthma and AR. For example, AD incidence did not show the male predominance during childhood, as occurred with asthma and AR (Table 2), nor have the same ecological association with altitude as that seen for asthma and AR (Fig. 2). With respect to the latter association, a more detailed analysis of our database indeed showed that AR incidence, but not AD incidence, progressively decreased above ∼1500 m altitude (data not shown), similar to the behavior of asthma incidence already reported by us.
This association between atopic diseases and altitude deserved a more in-depth analysis, and we will be reporting it in a forthcoming publication. Our results suggest that although the 3 diseases share an atopic background involving a type-2 inflammatory immune response, AD may have different underlying pathogenic mechanisms, a concept that needs further investigation. Likewise, these differences reinforce the notion that the tracheobronchial tree and the nose are part of a “common airway” affected by the same sensitization process manifested by asthma and AR, respectively.
Finally, it was clear that incidences of the studied atopic diseases progressively declined after 80 years of age, coinciding with the already reported low prevalence of allergic disease in this age-group.
Thus, the low rates of AD, AR and asthma in elderly people might be related to the well-known decrement of cellular and humoral immune responses with aging,
Strengths of our study were that: a) the extensive period analyzed (13 years) allowed us to confidently depict recent time trends of the major atopic diseases; b) a very large population ranging from ∼34.8 (2007) to ∼50.9 (2019) million insured subjects was evaluated, comprising ∼744,000 new cases of AD, AR or asthma diagnosed each year; c) we used incidence rates instead of prevalence, so a better picture of disease inception was obtained; and d) diagnoses were established by family physicians, avoiding the usual biases and large overestimation from questionnaires or surveys.
Conversely. because all patients were seen at first level medical units, which lack allergic skin tests or other procedures, a potential limitation of our study was that allergenic sensitization could not be confirmed. On the other hand, although it is possible that some degree of uncertainty exists in the accuracy of clinical diagnoses (specially the diagnosis of asthma in young children) or ICD codes capture, we consider that these would be minimal because in our institution it is mandatory for all family physicians to diagnose these atopic diseases according to established clinical practice guidelines, and encode technicians are trained personnel specialized in this task.
Conclusions
Herein we described the epidemiological profile of 3 major diseases involved in the atopic march (AD, AR, and asthma) during the life span in a very large population from a developing country. Our results showed that these diseases had their highest incidence in infancy and corroborated that, at least for asthma and AR, their incidence during childhood is higher in males, as compared with females, with a shift to a female predominance in adulthood. Additionally, we found that annual incidences of AR and asthma started to decline in most age-groups from ∼2009–2011 onward, and that the counties with the highest incidence of AR and asthma were those located at lower geographical altitude. Because AD exhibited a somewhat contrasting pattern with respect to AR and asthma, ie, a different age and sex distribution and a lack of association with geographical altitude, it is possible that its underlying mechanisms determining the atopic background differ from those of AR and asthma.
Funding source
None.
Authors’ contributions
MBA and MHV designed the study, performed the statistical analysis, interpreted the results and wrote the manuscript draft. ISMR and RARP contributed to data collection and critically reviewed the manuscript for important intellectual contribution. All authors read and approved the final manuscript.
Clinical Trial registration
Not applicable.
Ethics approval
Because this was a retrospective analysis of a de-identified institutional database, it was deemed unnecessary obtaining the approval from an ethics and scientific review board.
Authors’ consent for publication
All authors have read through and approved the publication of the manuscript.
Availability of data and materials
The original data are not publicly available because it is a very large institutional database with privacy restrictions.
Potential competing interests
The authors report no competing interests.
Appendix A. Supplementary data
The following is the Supplementary data to this article:
Becerril-Angeles M., Vargas M.H., Medina-Reyes I.S., Rascon-Pacheco R.A. Factors related to changes in the asthma male:female ratio by age in 403 Mexican counties. Ann Allergy Asthma Immunol. 2019;123(3):288-292 e1.
Instituto Mexicano del Seguro Social. Guía de práctica clínica. Diagnóstico y tratamiento del asma en mayores de 18 años. Evidencias y recomendaciones: Instituto Mexicano del Seguro Social; 2009. Available from: https://www.imss.gob.mx/sites/all/statics/guiasclinicas/000GER_Asma.pdf.
Instituto Mexicano del Seguro Social. Guía de práctica clínica. Diagnóstico y tratamiento de rinitis alérgica. Evidencias y recomendaciones. Ciudad de México: Instituto Mexicano del Seguro Social; 2017. Available from: https://www.imss.gob.mx/sites/all/statics/guiasclinicas/041GER.pdf.
Instituto Mexicano del Seguro Social. Guía de práctica clínica. Tratamiento de la dermatitis atópica. Evidencias y recomendaciones. Ciudad de Méxio: Instituto Mexicano del Seguro Social; 2014. Available from: https://www.imss.gob.mx/sites/all/statics/guiasclinicas/706GER.pdf.
Dirección General de Epidemiología, Secretaría de Salud, México. Anuario de Morbilidad 1984 -2020. https://epidemiologia.salud.gob.mx/anuario/html/index.html. Accessed March 23, 2022.
00108-9&id=gr1.jpg){kind=link}
00108-9&id=gr2.jpg){kind=link}
00108-9&id=gr3.jpg){kind=link}